Entereg(R) (alvimopan) Available For The Management Of Postoperative Ileus

Entereg® (alvimopan) capsules is now available to registered hospitals for helping patients recover gastrointestinal (GI) function earlier following bowel resection surgery. Entereg was approved by the U.S. Food and Drug Administration (FDA) on May 20, 2008, and is the first FDA-approved treatment for postoperative ileus (POI), a condition that affects almost all patients undergoing this type of surgery.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on June 11th, 2008